Logo image of CPIX

CUMBERLAND PHARMACEUTICALS (CPIX) Stock Fundamental Analysis

NASDAQ:CPIX - Nasdaq - US2307701092 - Common Stock

2.43  -0.1 (-3.95%)

Fundamental Rating

2

Overall CPIX gets a fundamental rating of 2 out of 10. We evaluated CPIX against 195 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of CPIX have multiple concerns. CPIX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year CPIX has reported negative net income.
CPIX had a negative operating cash flow in the past year.
CPIX had negative earnings in each of the past 5 years.
Each year in the past 5 years CPIX had a positive operating cash flow.
CPIX Yearly Net Income VS EBIT VS OCF VS FCFCPIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -14.16%, CPIX is in the better half of the industry, outperforming 67.20% of the companies in the same industry.
CPIX has a better Return On Equity (-43.87%) than 60.22% of its industry peers.
Industry RankSector Rank
ROA -14.16%
ROE -43.87%
ROIC N/A
ROA(3y)-5.94%
ROA(5y)-4.93%
ROE(3y)-14.92%
ROE(5y)-11.76%
ROIC(3y)N/A
ROIC(5y)N/A
CPIX Yearly ROA, ROE, ROICCPIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5 -10 -15 -20

1.3 Margins

CPIX has a better Gross Margin (83.31%) than 89.25% of its industry peers.
CPIX's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for CPIX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 83.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.02%
GM growth 5Y1.26%
CPIX Yearly Profit, Operating, Gross MarginsCPIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

CPIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CPIX has less shares outstanding
The number of shares outstanding for CPIX has been reduced compared to 5 years ago.
Compared to 1 year ago, CPIX has an improved debt to assets ratio.
CPIX Yearly Shares OutstandingCPIX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
CPIX Yearly Total Debt VS Total AssetsCPIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

CPIX has an Altman-Z score of 0.22. This is a bad value and indicates that CPIX is not financially healthy and even has some risk of bankruptcy.
CPIX has a Altman-Z score (0.22) which is in line with its industry peers.
CPIX has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
CPIX has a Debt to Equity ratio of 0.41. This is in the lower half of the industry: CPIX underperforms 62.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z 0.22
ROIC/WACCN/A
WACC10%
CPIX Yearly LT Debt VS Equity VS FCFCPIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

CPIX has a Current Ratio of 1.13. This is a normal value and indicates that CPIX is financially healthy and should not expect problems in meeting its short term obligations.
CPIX has a Current ratio of 1.13. This is amonst the worse of the industry: CPIX underperforms 83.33% of its industry peers.
CPIX has a Quick Ratio of 1.13. This is a bad value and indicates that CPIX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CPIX (0.99) is worse than 79.03% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.99
CPIX Yearly Current Assets VS Current LiabilitesCPIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for CPIX have decreased strongly by -170.83% in the last year.
CPIX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.47% yearly.
The Revenue has decreased by -6.45% in the past year.
CPIX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.16% yearly.
EPS 1Y (TTM)-170.83%
EPS 3Y14.47%
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)-6.45%
Revenue growth 3Y1.85%
Revenue growth 5Y6.16%
Sales Q2Q%-9.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CPIX Yearly Revenue VS EstimatesCPIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
CPIX Yearly EPS VS EstimatesCPIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 0.2 -0.2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CPIX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CPIX Price Earnings VS Forward Price EarningsCPIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CPIX Per share dataCPIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CPIX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CUMBERLAND PHARMACEUTICALS

NASDAQ:CPIX (1/21/2025, 8:00:00 PM)

2.43

-0.1 (-3.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)03-03 2025-03-03
Inst Owners14.87%
Inst Owner Change0%
Ins Owners3.35%
Ins Owner Change0.03%
Market Cap34.12M
Analysts43.33
Price TargetN/A
Short Float %6.09%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.93
P/FCF N/A
P/OCF N/A
P/B 1.38
P/tB 7.67
EV/EBITDA N/A
EPS(TTM)-0.17
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS2.62
BVpS1.76
TBVpS0.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.16%
ROE -43.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 83.31%
FCFM N/A
ROA(3y)-5.94%
ROA(5y)-4.93%
ROE(3y)-14.92%
ROE(5y)-11.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.02%
GM growth 5Y1.26%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.17%
Cap/Sales 0.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.99
Altman-Z 0.22
F-Score5
WACC10%
ROIC/WACCN/A
Cap/Depr(3y)18.6%
Cap/Depr(5y)24.68%
Cap/Sales(3y)2.36%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-170.83%
EPS 3Y14.47%
EPS 5YN/A
EPS Q2Q%-200%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.45%
Revenue growth 3Y1.85%
Revenue growth 5Y6.16%
Sales Q2Q%-9.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-127.4%
FCF growth 3Y19.45%
FCF growth 5YN/A
OCF growth 1Y-121.8%
OCF growth 3Y3.98%
OCF growth 5Y14.4%